15
H index
18
i10 index
746
Citations
Nancy Devlin : Citation Profile
University of Melbourne (47% share) | RESEARCH PRODUCTION: 70 Articles 8 Papers 4 Books RESEARCH ACTIVITY:
MORE DETAILS IN: ABOUT THIS REPORT:
|
28 years (1994 - 2022). Relations with other researchers
Works with:
Authors registered in RePEc who have co-authored more than one work in the last five years with Nancy Devlin. | Is cited by:
| Cites to:
|
Main data
Where Nancy Devlin has published?
| Journals with more than one article published | # docs |
|---|---|
| Health Economics | 16 |
| PharmacoEconomics | 15 |
| The European Journal of Health Economics | 12 |
| Health Policy | 6 |
| Applied Health Economics and Health Policy | 5 |
| Social Science & Medicine | 4 |
| Medical Decision Making | 4 |
| PharmacoEconomics - Open | 2 |
| The Patient: Patient-Centered Outcomes Research | 2 |
| Working Papers Series with more than one paper published | # docs |
|---|---|
| Working Papers / Centre for Health Economics, University of York | 5 |
| Monograph / Office of Health Economics | 4 |
Recent works citing Nancy Devlin (2024 and 2023)
| Year | Title of citing document | |
|---|---|---|
| 2024 | Whats in a Bill? A Model of Imperfect Moral Hazard in Healthcare. (2022). Zhu, ED ; Anderson, David M ; Hoagland, Alex. In: Papers. RePEc:arx:papers:2211.01116. Full description at Econpapers || Download paper | |
| 2023 | Using Limited Trial Evidence to Credibly Choose Treatment Dosage when Efficacy and Adverse Effects Weakly Increase with Dose. (2023). Manski, Charles F. In: Papers. RePEc:arx:papers:2305.17206. Full description at Econpapers || Download paper | |
| 2023 | The use of patient-reported outcome and experience measures for health policy purposes: A scoping review in oncology. (2023). Ferrua, M ; Fourcade, A ; Fierobe, A ; Minvielle, E ; Mir, O ; Scotte, F ; di Palma, M. In: Health Policy. RePEc:eee:hepoli:v:129:y:2023:i:c:s0168851022003165. Full description at Econpapers || Download paper | |
| 2023 | The functions of known to be inaccurate prices in markets: A cross-country comparison of pharmaceutical list pricing. (2023). Krafve, Linus Johansson ; Sjogren, Ebba ; Kjellberg, Hans. In: Journal of Business Research. RePEc:eee:jbrese:v:167:y:2023:i:c:s0148296323005520. Full description at Econpapers || Download paper | |
| 2023 | Barriers and facilitators to implementing priority setting and resource allocation tools in hospital decisions: A systematic review. (2023). Cutler, Henry ; Gu, Yuanyuan ; Seil, Elizabeth ; Bilgrami, Anam ; Jeet, Varinder ; Ahumada-Canale, Antonio. In: Social Science & Medicine. RePEc:eee:socmed:v:322:y:2023:i:c:s0277953623001478. Full description at Econpapers || Download paper | |
| 2023 | Randomised comparison of online interviews versus face-to-face interviews to value health states. (2023). Dalziel, Kim ; Yang, Yaling ; Rowen, Donna ; Devlin, Nancy ; Bourke, Mackenzie ; Peasgood, Tessa. In: Social Science & Medicine. RePEc:eee:socmed:v:323:y:2023:i:c:s0277953623001752. Full description at Econpapers || Download paper | |
| 2023 | Derivation of a UK preference-based value set for the Short Warwick-Edinburgh Mental Well-being Scale (SWEMWBS) to allow estimation of Mental Well-being Adjusted Life Years (MWALYs). (2023). Madan, Jason ; Stewart-Brown, Sarah ; Petrou, Stavros ; Buckell, John ; Edmund, Hei Hang. In: Social Science & Medicine. RePEc:eee:socmed:v:327:y:2023:i:c:s027795362300285x. Full description at Econpapers || Download paper | |
| 2023 | Algorithms and heuristics of health technology assessments: A retrospective analysis of factors associated with HTA outcomes for new drugs across seven OECD countries. (2023). Gentilini, Arianna ; Visintin, Erica ; Kanavos, Panos. In: Social Science & Medicine. RePEc:eee:socmed:v:331:y:2023:i:c:s0277953623004021. Full description at Econpapers || Download paper | |
| 2023 | Identifying the value of a clinical information system during the COVID-19 pandemic. (2023). Jones, Paul ; Madhavan, Naveen. In: Technovation. RePEc:eee:techno:v:120:y:2023:i:c:s0166497221002273. Full description at Econpapers || Download paper | |
| 2023 | Making an economic argument for investment in global mental health: the case of conflict-affected refugees and displaced people. (2023). Park, A-La ; McDaid, David. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:118149. Full description at Econpapers || Download paper | |
| 2023 | Open and inclusive: fair processes for financing universal health coverage. (2023). Kurowski, Christoph. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:119795. Full description at Econpapers || Download paper | |
| 2023 | . Full description at Econpapers || Download paper | |
| 2023 | . Full description at Econpapers || Download paper | |
| 2023 | . Full description at Econpapers || Download paper | |
| 2023 | . Full description at Econpapers || Download paper | |
| 2023 | . Full description at Econpapers || Download paper | |
| 2023 | National Quality and Sustainable Development: An Empirical Analysis Based on China’s Provincial Panel Data. (2023). Wang, Yu Kun ; Liu, Duochenxi ; You, Shibing. In: Sustainability. RePEc:gam:jsusta:v:15:y:2023:i:6:p:4879-:d:1092320. Full description at Econpapers || Download paper | |
| 2023 | Effect of price transparency on the perception of fair price and satisfaction with the purchase of sports products. (2023). Aghaei, Malihe Sadat ; Mirzazadeh, Zahra Sadat ; Sepehrian, Amir Hossein. In: Journal of Revenue and Pricing Management. RePEc:pal:jorapm:v:22:y:2023:i:5:d:10.1057_s41272-022-00391-w. Full description at Econpapers || Download paper | |
| 2024 | Economic Evaluation under Ambiguity and Structural Uncertainties. (2023). Andrews, Brendon. In: Working Papers. RePEc:ris:albaec:2023_009. Full description at Econpapers || Download paper | |
| 2023 | Comparing EQ-5D-3L and EQ-5D-5L in measuring the HRQoL burden of 4 health conditions in China. (2023). Li, Sha ; Yang, Zhihao ; Jiang, Jie ; Mukuria, Clara ; Luo, Nan ; Hong, Yanming ; Weng, Guizhi. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:2:d:10.1007_s10198-022-01465-7. Full description at Econpapers || Download paper | |
| 2023 | Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology. (2023). Attema, Arthur ; Shah, Koonal K ; Zhang, Liying ; Lipman, Stefan A. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:2:d:10.1007_s10198-022-01466-6. Full description at Econpapers || Download paper | |
| 2023 | A hearing bolt-on item increased the measurement properties of the EQ-5D-5L in a community-based hearing loss screening program. (2023). Luo, Nan ; Tan, Rachel Lee-Yin ; Chong, Sheue-Lih ; Wang, Pei. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:3:d:10.1007_s10198-022-01479-1. Full description at Econpapers || Download paper | |
| 2023 | Completing the time trade-off with respondents who are older, in poorer health or with an immigrant background in an EQ-5D-5L valuation study. (2023). Rand, Kim ; Stavem, Knut ; Hansen, Tonya Moen. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:6:d:10.1007_s10198-022-01517-y. Full description at Econpapers || Download paper | |
| 2023 | Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand. (2023). Blizzard, Leigh C ; Palmer, Andrew J ; Carroll, William M ; Butzkueven, Helmut ; Simpson-Yap, Steve ; Kalincik, Tomas ; Mason, Deborah F ; Norman, Richard ; Taylor, Bruce V ; Campbell, Julie A ; Henson, Glen J ; Claflin, Suzi ; van der Mei, Ingrid. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:6:d:10.1007_s10198-022-01518-x. Full description at Econpapers || Download 2023 | Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients. (2023). Wang, Pei ; Luo, Nan ; Zhao, Chun-Hua ; Zhu, Yan-Bo ; He, Jun-Yi ; Pan, Chen-Wei. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:6:d:10.1007_s10198-022-01523-0. Full description at Econpapers || Download paper |
| 2023 | Health technology assessment criteria as drivers of coverage with managed entry agreements: a case study of cancer medicines in four countries. (2023). Efthymiadou, Olina. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:7:d:10.1007_s10198-022-01526-x. Full description at Econpapers || Download paper | |
| 2023 | What if 0 is not equal to 0? Inter-personal health utilities anchoring using the largest health gains. (2023). Jakubczyk, Micha. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:7:d:10.1007_s10198-022-01537-8. Full description at Econpapers || Download paper | |
| 2023 | To what extent does the use of crosswalks instead of EQ-5D value sets impact reimbursement decisions?: a simulation study. (2023). Dongen, Johanna M ; Ben, Angela Jornada ; Bosmans, Judith E ; el Alili, Mohamed ; Finch, Aureliano Paolo. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:8:d:10.1007_s10198-022-01539-6. Full description at Econpapers || Download paper | |
| 2023 | Developing an Australian utility value set for the Early Childhood Oral Health Impact Scale-4D (ECOHIS-4D) using a discrete choice experiment. (2023). Arrow, Peter ; Hettiarachchi, Ruvini M ; Kularatna, Sanjeewa ; Jamieson, Lisa ; Tonmukayawul, Utsana ; Norman, Richard ; Brain, David ; Carter, Hannah ; Senanayake, Sameera. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:8:d:10.1007_s10198-022-01542-x. Full description at Econpapers || Download 2023 | Systematic Review of the Effect of a One-Day Versus Seven-Day Recall Duration on Patient Reported Outcome Measures (PROMs). (2023). Mukuria, Clara ; Caruana, Julia M ; Peasgood, Tessa. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:16:y:2023:i:3:d:10.1007_s40271-022-00611-w. Full description at Econpapers || Download paper |
| 2023 | Including Young Children in the Development and Testing of Patient Reported Outcome (PRO) Instruments: A Scoping Review of Children’s Involvement and Qualitative Methods. (2023). Carlton, Jill ; Gale, Victoria. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:16:y:2023:i:5:d:10.1007_s40271-023-00637-8. Full description at Econpapers || Download paper | |
| 2023 | The Egyptian EQ-5D-5L Extensive Pilot Study: Lessons Learned. (2023). Farid, Samar ; Stolk, Elly ; Finch, Aureliano ; Abbassi, Maggie ; Roudijk, Bram ; al Shabasy, Sahar. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:3:d:10.1007_s40273-022-01208-9. Full description at Econpapers || Download paper | |
| 2023 | Estimation of Health Utility Scores for Glycogen Storage Disease Type Ia. (2023). Lloyd, Andrew ; Freitas, Hayley ; Aggio, Daniel ; Kruger, Eliza. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:7:y:2023:i:4:d:10.1007_s41669-023-00397-z. Full description at Econpapers || Download paper | |
| 2023 | Cost-Effectiveness Analysis of Siltuximab for Australian Public Investment in the Rare Condition Idiopathic Multicentric Castleman Disease. (2023). Rutherford, Carolyn ; Kirchmann, Matt ; Zibelnik, Natasa ; Wayi-Wayi, Grace ; Ademi, Zanfina ; Abrams, Keith R ; Shupo, Francis ; Makarounas-Kirchmann, Kelly. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:7:y:2023:i:5:d:10.1007_s41669-023-00426-x. Full description at Econpapers || Download paper | |
| 2023 | What are Valid Weights for the Human Development Index? A Discrete Choice Experiment for the United Kingdom. (2023). Feeny, Simon ; Ombler, Franz ; Knowles, Stephen ; Hansen, Paul ; McGillivray, Mark. In: Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement. RePEc:spr:soinre:v:165:y:2023:i:2:d:10.1007_s11205-022-03039-9. Full description at Econpapers || Download paper | |
| 2023 | The effects of price transparency and debt collection policies on intentions to consume recommended health care: A randomized vignette experiment. (2023). Ko, Hansoo ; Epstein, Wendy Netter ; Robertson, Christopher T. In: Journal of Empirical Legal Studies. RePEc:wly:empleg:v:20:y:2023:i:4:p:941-960. Full description at Econpapers || Download paper |
Works by Nancy Devlin:
| Year | Title | Type | Cited |
|---|---|---|---|
| 1995 | Comment: Financing New Zealand’s Tertiary Education: How Much Subsidy? In: Agenda - A Journal of Policy Analysis and Reform. [Full Text][Citation analysis] | article | 0 |
| 1994 | The effects of denturism: New Zealand dentists response to competition In: American Journal of Public Health. [Citation analysis] | article | 0 |
| 2000 | The health state preferences and logistical inconsistencies of New Zealanders: a tale of two tariffs In: Working Papers. [Full Text][Citation analysis] | paper | 6 |
| 2011 | Truly inefficient or providing better quality of care? Analysing the relationship between riskadjusted hospital costs and patients’ health outcomes In: Working Papers. [Full Text][Citation analysis] | paper | 21 |
| 2013 | TRULY INEFFICIENT OR PROVIDING BETTER QUALITY OF CARE? ANALYSING THE RELATIONSHIP BETWEEN RISK?ADJUSTED HOSPITAL COSTS AND PATIENTS HEALTH OUTCOMES.(2013) In: Health Economics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 21 | article | |
| 2012 | Analysing Hospital Variation in Health Outcome at the Level of EQ-5D Dimensions In: Working Papers. [Full Text][Citation analysis] | paper | 1 |
| 2013 | Methods for the estimation of the NICE cost effectiveness threshold In: Working Papers. [Full Text][Citation analysis] | paper | 49 |
| 2013 | The influence of cost-effectiveness and other factors on NICE decisions In: Working Papers. [Full Text][Citation analysis] | paper | 25 |
| 2015 | The Influence of Cost?Effectiveness and Other Factors on Nice Decisions.(2015) In: Health Economics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 25 | article | |
| 2015 | Local health care expenditure plans and their opportunity costs In: Health Policy. [Full Text][Citation analysis] | article | 4 |
| 2020 | Do people with private health insurance attach a higher value to health than those without insurance? Results from an EQ-5D-5 L valuation study in Ireland In: Health Policy. [Full Text][Citation analysis] | article | 1 |
| 2020 | The impact of price transparency on consumers and providers: A scoping review In: Health Policy. [Full Text][Citation analysis] | article | 5 |
| 1996 | The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand In: Health Policy. [Full Text][Citation analysis] | article | 8 |
| 2006 | Yes, No or Yes, but? Multinomial modelling of NICE decision-making In: Health Policy. [Full Text][Citation analysis] | article | 7 |
| 2009 | Searching for cost effectiveness thresholds in the NHS In: Health Policy. [Full Text][Citation analysis] | article | 26 |
| 2020 | A new tool for creating personal and social EQ-5D-5L value sets, including valuing ‘dead’ In: Social Science & Medicine. [Full Text][Citation analysis] | article | 5 |
| 1999 | The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule In: Social Science & Medicine. [Full Text][Citation analysis] | article | 3 |
| 2005 | Continuity through change: The rhetoric and reality of health reform in New Zealand In: Social Science & Medicine. [Full Text][Citation analysis] | article | 9 |
| 2009 | A note on the nature of utility in time and health and implications for cost utility analysis In: Social Science & Medicine. [Full Text][Citation analysis] | article | 6 |
| 2009 | Identifying the impact of government targets on waiting times in the NHS In: Health Care Management Science. [Full Text][Citation analysis] | article | 32 |
| 2000 | Allocating Vote: Health — ‘Needs Assessment’ and an Economics-Based Approach In: Treasury Working Paper Series. [Full Text][Citation analysis] | paper | 0 |
| 2016 | “New Age” Decision Making in HTA: Is It Applicable in Asia? In: Briefing. [Full Text][Citation analysis] | paper | 0 |
| 2011 | Incorporating Multiple Criteria in HTA: Methods and Processes In: Monograph. [Full Text][Citation analysis] | book | 22 |
| 2010 | Getting the Most out of PROMs: Putting Health Outcomes at the Heart of NHS Decision-Making In: Monograph. [Full Text][Citation analysis] | book | 21 |
| 2002 | Cost-Effectiveness Thresholds: Economic and ethical issues In: Monograph. [Full Text][Citation analysis] | book | 20 |
| 2004 | How Much Should We Spend on the NHS? In: Monograph. [Full Text][Citation analysis] | book | 2 |
| 2012 | Time to tweak the TTO. But how? In: MPRA Paper. [Full Text][Citation analysis] | paper | 1 |
| 2010 | Statistical Analysis of EQ-5D Profiles: Does the Use of Value Sets Bias Inference? In: Medical Decision Making. [Full Text][Citation analysis] | article | 8 |
| 2010 | Protocols for Time Tradeoff Valuations of Health States Worse than Dead: A Literature Review In: Medical Decision Making. [Full Text][Citation analysis] | article | 9 |
| 2013 | Hospital Variation in Patient-Reported Outcomes at the Level of EQ-5D Dimensions In: Medical Decision Making. [Full Text][Citation analysis] | article | 10 |
| 2016 | What Determines the Shape of an EQ-5D Index Distribution? In: Medical Decision Making. [Full Text][Citation analysis] | article | 2 |
| 2017 | EQ-5D and the EuroQol Group: Past, Present and Future In: Applied Health Economics and Health Policy. [Full Text][Citation analysis] | article | 38 |
| 2017 | A Review of NICE Methods and Processes Across Health Technology Assessment Programmes: Why the Differences and What is the Impact? In: Applied Health Economics and Health Policy. [Full Text][Citation analysis] | article | 4 |
| 2021 | Allocating Public Spending Efficiently: Is There a Need for a Better Mechanism to Inform Decisions in the UK and Elsewhere? In: Applied Health Economics and Health Policy. [Full Text][Citation analysis] | article | 2 |
| 2021 | EQ-5D-5L Health-State Values for the Mexican Population In: Applied Health Economics and Health Policy. [Full Text][Citation analysis] | article | 1 |
| 2022 | Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy In: Applied Health Economics and Health Policy. [Full Text][Citation analysis] | article | 0 |
| 2013 | The development of new research methods for the valuation of EQ-5D-5L In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 9 |
| 2013 | The effects of lead time and visual aids in TTO valuation: a study of the EQ-VT framework In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 3 |
| 2013 | Lead versus lag-time trade-off variants: does it make any difference? In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 1 |
| 2013 | Time to tweak the TTO: results from a comparison of alternative specifications of the TTO In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 3 |
| 2013 | One-to-one versus group setting for conducting computer-assisted TTO studies: findings from pilot studies in England and the Netherlands In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 3 |
| 2017 | Head-to-head comparison of health-state values derived by a probabilistic choice model and scores on a visual analogue scale In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 2 |
| 2018 | Valuing EQ-5D-5L health states ‘in context’ using a discrete choice experiment In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 3 |
| 2019 | Impact of mapped EQ-5D utilities on cost-effectiveness analysis: in the case of dialysis treatments In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 1 |
| 2019 | A new method for valuing health: directly eliciting personal utility functions In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 5 |
| 2020 | An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y values In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 3 |
| 2021 | What is the best approach to adopt for identifying the domains for a new measure of health, social care and carer-related quality of life to measure quality-adjusted life years? Application to the dev In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 2 |
| 2005 | A ‘new and improved’ EQ-5D valuation questionnaire? In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 2 |
| 2017 | Assessing Preference-Based Outcome Measures for Overactive Bladder: An Evaluation of Patient-Reported Outcome Data from the BESIDE Clinical Trial In: The Patient: Patient-Centered Outcomes Research. [Full Text][Citation analysis] | article | 0 |
| 2021 | Giving a Voice to Marginalised Groups for Health Care Decision Making In: The Patient: Patient-Centered Outcomes Research. [Full Text][Citation analysis] | article | 0 |
| 2010 | An Analysis of NICE’s ‘Restricted’ (or ‘Optimized’) Decisions In: PharmacoEconomics. [Full Text][Citation analysis] | article | 2 |
| 2013 | Operationalizing Value-Based Pricing of Medicines In: PharmacoEconomics. [Full Text][Citation analysis] | article | 12 |
| 2015 | A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE) In: PharmacoEconomics. [Full Text][Citation analysis] | article | 5 |
| 2018 | Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L In: PharmacoEconomics. [Full Text][Citation analysis] | article | 4 |
| 2018 | 3L, 5L, What the L? A NICE Conundrum In: PharmacoEconomics. [Full Text][Citation analysis] | article | 2 |
| 2018 | Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets In: PharmacoEconomics. [Full Text][Citation analysis] | article | 6 |
| 2018 | Correction to: Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets In: PharmacoEconomics. [Full Text][Citation analysis] | article | 1 |
| 2018 | Correction to: 3L, 5L, What the L? A NICE Conundrum In: PharmacoEconomics. [Full Text][Citation analysis] | article | 2 |
| 2020 | Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going? In: PharmacoEconomics. [Full Text][Citation analysis] | article | 7 |
| 2020 | International Valuation Protocol for the EQ-5D-Y-3L In: PharmacoEconomics. [Full Text][Citation analysis] | article | 2 |
| 2022 | How are Child-Specific Utility Instruments Used in Decision Making in Australia? A Review of Pharmaceutical Benefits Advisory Committee Public Summary Documents In: PharmacoEconomics. [Full Text][Citation analysis] | article | 0 |
| 2022 | A Comparison of PROPr and EQ-5D-5L Value Sets In: PharmacoEconomics. [Full Text][Citation analysis] | article | 1 |
| 2022 | Systematic Review of Conceptual, Age, Measurement and Valuation Considerations for Generic Multidimensional Childhood Patient-Reported Outcome Measures In: PharmacoEconomics. [Full Text][Citation analysis] | article | 1 |
| 2022 | Correction to: Systematic Review of Conceptual, Age, Measurement and Valuation Considerations for Generic Multidimensional Childhood Patient-Reported Outcome Measures In: PharmacoEconomics. [Full Text][Citation analysis] | article | 1 |
| 2022 | Preference Elicitation Techniques Used in Valuing Children’s Health-Related Quality-of-Life: A Systematic Review In: PharmacoEconomics. [Full Text][Citation analysis] | article | 0 |
| 2018 | Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL) In: PharmacoEconomics - Open. [Full Text][Citation analysis] | article | 1 |
| 2019 | All Male Panels and Other Diversity Considerations for ISPOR In: PharmacoEconomics - Open. [Full Text][Citation analysis] | article | 0 |
| 2001 | Health care spending and economic output: Granger causality In: Applied Economics Letters. [Full Text][Citation analysis] | article | 56 |
| 2002 | The Purchasing of Health Care by Primary Care Organisations. An evaluation and Guide to Future Policy, by N. Mays, S. Wyke, G. Malbon, N. Goodwin. Open University Press, Buckingham and Philadelphia, 2 In: Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2003 | Logical inconsistencies in survey respondents health state valuations ? a methodological challenge for estimating social tariffs In: Health Economics. [Full Text][Citation analysis] | article | 19 |
| 2004 | Does NICE have a cost?effectiveness threshold and what other factors influence its decisions? A binary choice analysis In: Health Economics. [Full Text][Citation analysis] | article | 110 |
| 2004 | Getting Health Economics into Practice, Edited by David Kernick. Radcliffe Medical Press, Oxford, 2002. No. of pages: 358. ISBN 1?85775?575?8 In: Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2006 | A theoretical framework for TTO valuations of health In: Health Economics. [Full Text][Citation analysis] | article | 6 |
| 2006 | Is there a case for using visual analogue scale valuations in cost?utility analysis? In: Health Economics. [Full Text][Citation analysis] | article | 30 |
| 2007 | ‘Is there a case for using visual analogue scale valuations in CUA? Yes there is a case, but what does it add to ordinal data?’ a rejoinder In: Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2010 | Patient?reported outcome measures in the NHS: new methods for analysing and reporting EQ?5D data In: Health Economics. [Full Text][Citation analysis] | article | 9 |
| 2011 | A uniform time trade off method for states better and worse than dead: feasibility study of the ‘lead time’ approach In: Health Economics. [Full Text][Citation analysis] | article | 29 |
| 2013 | A COMPARISON OF ALTERNATIVE VARIANTS OF THE LEAD AND LAG TIME TTO In: Health Economics. [Full Text][Citation analysis] | article | 14 |
| 2015 | INTER?PROVIDER COMPARISON OF PATIENT?REPORTED OUTCOMES: DEVELOPING AN ADJUSTMENT TO ACCOUNT FOR DIFFERENCES IN PATIENT CASE MIX In: Health Economics. [Full Text][Citation analysis] | article | 2 |
| 2018 | New methods for modelling EQ?5D?5L value sets: An application to English data In: Health Economics. [Full Text][Citation analysis] | article | 9 |
| 2018 | Valuing health?related quality of life: An EQ?5D?5L value set for England In: Health Economics. [Full Text][Citation analysis] | article | 29 |
| 2021 | Population norms for quality adjusted life years for the United States of America, China, the United Kingdom and Australia In: Health Economics. [Full Text][Citation analysis] | article | 1 |
CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated March, 4 2024. Contact: CitEc Team